Is IBM stock a buy after its historic 25% single-day crash? Here is what analysts say

IBM shares extended their selloff, dropping more than 2.7% Wednesday after Tuesday’s 25% plunge erased roughly $67B–$70B in market value. Analysts cautioned that shifting corporate technology spending priorities could keep pressuring the stock even as IBM highlights long-term AI ambitions.

Analysis

The market is signaling that IBM is being treated less like a durable AI compounder and more like a legacy IT budget casualty. The first-order damage is not just multiple compression; it is the risk that enterprise buyers are shifting spend toward vendors with clearer near-term ROI, which can pressure IBM's consulting and software mix before any AI monetization offsets it. In other words, the stock is being repriced on earnings durability, not narrative optionality.

The next 1-3 months matter more than the long-term AI story. After a move this large, positioning will be fragile and any soft commentary on bookings, backlog conversion, or customer decision cycles could force another leg down as investors de-risk "old-tech turnaround" exposures. By contrast, the structural winners are likely the vendors capturing incremental AI and cloud budgets with faster deployment cycles — hyperscalers and infrastructure names that can show usage-based revenue sooner than IBM can prove enterprise AI payback.

Contrarian view: the selloff may be overshooting if the market is implicitly assuming a broad capex freeze rather than a budget reallocation. If IBM can defend recurring revenue and show that AI attach rates are additive rather than cannibalistic, the current drawdown could become a tradable exhaustion event. What would falsify the bearish thesis is a stabilizing guide, no deterioration in backlog, or evidence that AI deals are converting into measurable pipeline faster than the market expects.

Key Decisions for Investors

• Short IBM on failed rebounds over the next 1-3 weeks; use the post-crash volatility as an entry advantage rather than chasing the gap down. Risk/reward favors a tactical short while sentiment remains washed out, with the thesis invalidated by any positive guide revision or stabilization in bookings.
• Pair trade: long MSFT / short IBM for a 1-3 month view. MSFT is better positioned to capture enterprise AI budget reallocation, while IBM faces the risk that clients prefer platforms with faster deployment and clearer monetization.
• If you want lower beta exposure, prefer XLK or SMH over IBM on the next tech allocation cycle; IBM is vulnerable to multiple de-rating if investors continue rotating to higher-growth AI infrastructure proxies.
• Set an alert for IBM earnings commentary on backlog, consulting demand, and AI pipeline conversion. A clean defense of recurring revenue would force shorts to cover; absent that, the downside can persist for several months.